Details of transplantation
| UPN . | Age at HSCT . | Donor . | Mismatch (HLA-A, -B, -DR) . | Graft . | T-cell depletion . | Conditioning . | Bu dosage, mg/kg . | GvHD prophylaxis . | GvHD grade II or higher, acute/chronic . | Outcome . |
|---|---|---|---|---|---|---|---|---|---|---|
| U466 | 2 mo | MSD | 0 | BM | No | None | No | No | No/no | Alive |
| U396 | 3 mo | MFD | 0 | BM | No | None | No | No | No/no | Alive |
| U301 | 2 mo | MFD | 0 | BM | No | None | No | CSA | No/no | Alive |
| U175 | 3 mo | MSD | 0 | BM | No | None | No | PDN | II/no | Alive |
| U118 | 3 mo | MSD | 0 | BM | No | None | No | CSA | No/no | Alive |
| M1052 | 5 mo | MSD | 0 | BM | No | None | No | No | No/no | Alive |
| M1053 | 5 mo | MSD | 0 | BM | No | None | No | No | No/no | Alive |
| U442 | 1 y 5 mo | MUD | 1 | PBSC | Yes | Bu, Cy | 13 | No | No/no | Alive |
| U457 | 2 y 6 mo | MUD | 0 | BM | No | Bu, Cy | 16 | CSA, MTX | No/no | Death day +61, CMV, adenovirus |
| U444 | 2 mo | MMFD | 3 | PBSC | Yes | Bu, Cy | 13 | No | No/no | Alive |
| U322 | 4 mo | MMFD | 3 | PBSC | Yes | Bu, Cy | 8 | No | No/no | Death day +34, aspergillosis |
| U66 | 2 mo | MMFD | 3 | BM | Yes | Bu, Cy | 8 | No | III/No | Death day +23, aspergillosis |
| U51 | 6 mo | MMFD | 3 | BM | Yes | Bu, Cy | 8 | No | II/yes | Alive |
| U36 | 4 mo | MMFD | 3 | BM | Yes | Bu, Cy | 8 | No | No/no | Alive |
| U26 | 8 mo | MMFD | 3 | BM | Yes | Bu, Cy | 12 | No | No/no | Alive |
| UPN . | Age at HSCT . | Donor . | Mismatch (HLA-A, -B, -DR) . | Graft . | T-cell depletion . | Conditioning . | Bu dosage, mg/kg . | GvHD prophylaxis . | GvHD grade II or higher, acute/chronic . | Outcome . |
|---|---|---|---|---|---|---|---|---|---|---|
| U466 | 2 mo | MSD | 0 | BM | No | None | No | No | No/no | Alive |
| U396 | 3 mo | MFD | 0 | BM | No | None | No | No | No/no | Alive |
| U301 | 2 mo | MFD | 0 | BM | No | None | No | CSA | No/no | Alive |
| U175 | 3 mo | MSD | 0 | BM | No | None | No | PDN | II/no | Alive |
| U118 | 3 mo | MSD | 0 | BM | No | None | No | CSA | No/no | Alive |
| M1052 | 5 mo | MSD | 0 | BM | No | None | No | No | No/no | Alive |
| M1053 | 5 mo | MSD | 0 | BM | No | None | No | No | No/no | Alive |
| U442 | 1 y 5 mo | MUD | 1 | PBSC | Yes | Bu, Cy | 13 | No | No/no | Alive |
| U457 | 2 y 6 mo | MUD | 0 | BM | No | Bu, Cy | 16 | CSA, MTX | No/no | Death day +61, CMV, adenovirus |
| U444 | 2 mo | MMFD | 3 | PBSC | Yes | Bu, Cy | 13 | No | No/no | Alive |
| U322 | 4 mo | MMFD | 3 | PBSC | Yes | Bu, Cy | 8 | No | No/no | Death day +34, aspergillosis |
| U66 | 2 mo | MMFD | 3 | BM | Yes | Bu, Cy | 8 | No | III/No | Death day +23, aspergillosis |
| U51 | 6 mo | MMFD | 3 | BM | Yes | Bu, Cy | 8 | No | II/yes | Alive |
| U36 | 4 mo | MMFD | 3 | BM | Yes | Bu, Cy | 8 | No | No/no | Alive |
| U26 | 8 mo | MMFD | 3 | BM | Yes | Bu, Cy | 12 | No | No/no | Alive |
Bu indicates busulfan; MSD, matched sibling donor; BM, bone marrow; CSA, cyclosporine A; PDN, prednisolone; PBSC, peripheral blood stem cells; Cy, cyclophosphamide (4 × 50 mg/kg); MTX, methotrexate; and CMV, cytomegalovirus.